BofA raised the firm’s price target on Waters (WAT) to $370 from $350 and keeps a Neutral rating on the shares after having hosted CFO Amol Chaubal and other executives for an investor dinner at BofA’s Healthcare Conference. The analyst left the meeting “encouraged,” but reiterates a Neutral rating given the stock’s premium valuation and uncertain market fundamentals.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WAT: